Latest news on the STEPS-EA trial

Posted on 31 March 2021

The STEPS-EA trial is an ERNICA multi-centre randomised controlled trial looking at intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection.

Click here to access the latest STEPS-EA updates, via their newsletter (March 2021 issue)

For more information about the STEPS-EA trial, you can watch the explainer video on our YouTube channel.